CIK: 1376099 - Address: C/O Dyadic International, Inc., 1044 North U.S. Highway One, Suite 201, Jupiter, FL 33477-5094
12 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11234070131274605187
P%wins100505050505058
S%ret112-201-94-38-9
S%wins505050100010058

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/4/24 20:00
1/3/24
DYAIDyadic International IncDEHealthBioPrdBiological Products, (No DiagKaye JackFLDM.d00.0002742434D
6/20/23 17:23
6/16/23
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKaye JackP7DS.d-4318.930-2-634D
3/1/23 16:10
2/27/23
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKaye JackP7DS-819.9900-128D
3/2/22 17:42
2/28/22
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKaye JackP7DS-1016.760-1-319D
3/4/21 14:28
3/2/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKaye JackP7DS-1937.600-1-318D
1/30/20 21:32
1/28/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKaye JackP7DS-5062.200-1-514D
1/31/19 17:19
1/28/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKaye JackP7DS-3831.310-1-715D
1/31/18 10:34
1/29/18
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKaye JackP7DS-5318.530-3-1813D
12/8/10 19:31
12/6/10
KERXKeryx Biopharmaceuticals IncDEHealthDrugPharmaceutical PreparationsKaye JackNYDS-1005.008-20-12141D999482721-13-5-8-422-5-154-38
10/1/10 18:00
9/29/10
KERXKeryx Biopharmaceuticals IncDEHealthDrugPharmaceutical PreparationsKaye JackNYDS-1265.026-25-13161D999106763726231-1-5-27-34-38
5/22/09 16:45
5/22/09
KERXKeryx Biopharmaceuticals IncDEHealthDrugPharmaceutical PreparationsKaye JackNYDP150.42900355796D-97-2994169119406-8581152264561999
6/22/07 06:04
6/19/07
KERXKeryx Biopharmaceuticals IncDEHealthDrugPharmaceutical PreparationsKaye JackNYDP.d1510.5061New1I-20-19-26-8-1-9-6-40-2-13-2-13-95

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact